Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Simon, G. E. Search for Related Content PubMed Citation Articles by Simon, G. E. Primary Care Depression Other Psychotherapy Antidepressants Epidemiology

Prevalence and Predictors of Depression Treatment in an International Primary Care Study

OBJECTIVE: The purpose of the study was to evaluate the prevalence and predictors of depression treatment in a diverse cross-national sample of primary care patients. METHOD: At primary care facilities in six countries (Spain, Israel, Australia, Brazil, Russia, and the United States), a two-stage screening process was used to identify 1,117 patients with current depressive disorder. At baseline, all patients completed a structured diagnostic interview as well as measures of anxiety symptoms, alcohol use, chronic comorbid physical conditions, and perceived barriers to treatment. Primary care physicians were advised if the research interview indicated a probable depressive disorder in their patients. Three and 9 months later, participants reported all health services (including specialty mental health care and antidepressant medication) used in the preceding 3 months. RESULTS: Across the six sites, the proportion of patients receiving any antidepressant pharmacotherapy ranged from a high of 38% in Seattle to a low of 0% in St. Petersburg; the proportion receiving any specialty mental health care varied from a high of 29% in Melbourne to a low of 3% in St. Petersburg. Patient characteristics were not consistently associated with receipt of either pharmacotherapy or specialty mental health care. Out-of-pocket cost was the most commonly reported barrier to treatment for depression; the percentage of patients who reported this barrier ranged from 24% in Barcelona to 75% in St. Petersburg. CONCLUSIONS: Depression screening and physician notification are not sufficient to prompt adequate treatment for depression. The probability of treatment may be more influenced by characteristics of health care systems than by the clinical characteristics of individual patients. Financial barriers may be more important than stigma as impediments to appropriate care.

This article has been cited by other articles:

				S. Dietrich, R. Mergl, P. Freudenberg, D. Althaus, and U. Hegerl Impact of a campaign on the public's attitudes towards depression Health Educ. Res., September 13, 2009; (2009) cyp050v1. [Abstract] [Full Text] [PDF]

				M. Kivimaki, G. D. Batty, A. Singh-Manoux, H. Nabi, S. Sabia, A. G. Tabak, T. N. Akbaraly, J. Vahtera, M. G. Marmot, and M. Jokela Association between common mental disorder and obesity over the adult life course The British Journal of Psychiatry, August 1, 2009; 195(2): 149 - 155. [Abstract] [Full Text] [PDF]

				R. Mojtabai Unmet Need for Treatment of Major Depression in the United States Psychiatr Serv, March 1, 2009; 60(3): 297 - 305. [Abstract] [Full Text] [PDF]

				S. A. Epstein, L. M. Hooper, K. P. Weinfurt, V. DePuy, L. A. Cooper, W. G. Harless, and C. M. Tracy Primary Care Physicians' Evaluation and Treatment of Depression: Results of an Experimental Study Using Video Vignettes Med Care Res Rev, December 1, 2008; 65(6): 674 - 695. [Abstract] [PDF]

				I. Colman, T. J. Croudace, M. E. J. Wadsworth, D. Kuh, and P. B. Jones Psychiatric outcomes 10 years after treatment with antidepressants or anxiolytics The British Journal of Psychiatry, October 1, 2008; 193(4): 327 - 331. [Abstract] [Full Text] [PDF]

				I. Anderson, I. Ferrier, R. Baldwin, P. Cowen, L Howard, G Lewis, K Matthews, R. McAllister-Williams, R. Peveler, J Scott, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines J Psychopharmacol, June 1, 2008; 22(4): 343 - 396. [Abstract] [PDF]

				J. C. Coyne and S. C. Marcus Health Disparities in Care for Depression Possibly Obscured by the Clinical Significance Criterion Am J Psychiatry, September 1, 2006; 163(9): 1577 - 1579. [Abstract] [Full Text] [PDF]

				I. Colman, M. E. J. Wadsworth, T. J. Croudace, and P. B. Jones Three decades of antidepressant, anxiolytic and hypnotic use in a national population birth cohort The British Journal of Psychiatry, August 1, 2006; 189(2): 156 - 160. [Abstract] [Full Text] [PDF]

				M. BOBAK, H. PIKHART, A. PAJAK, R. KUBINOVA, S. MALYUTINA, H. SEBAKOVA, R. TOPOR-MADRY, Y. NIKITIN, and M. MARMOT Depressive symptoms in urban population samples in Russia, Poland and the Czech Republic The British Journal of Psychiatry, April 1, 2006; 188(4): 359 - 365. [Abstract] [Full Text] [PDF]

				F. Fregni, P. S. Boggio, M. Nitsche, and A. Pascual-Leone Transcranial direct current stimulation The British Journal of Psychiatry, May 1, 2005; 186(5): 446 - 447. [Full Text] [PDF]

				G. Thornicroft and D. Rose Mental health in Europe BMJ, March 19, 2005; 330(7492): 613 - 614. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us